Replies to post #89939 on Biotech Values

[dewophile]

Abbott currently has three HCV compounds in human trials [two of these are ABT-450 and ABT-333 (#msg-46036079); I don’t know what the third one is

i think it's ABT-072, a NNPI (unless it was discontinued)

[rkrw]

I'm amazed Niaspan is now a $1B drug. At one point Kosp was a micro cap surviving on loans from the founder/chairman.